13F Data
13F filer · CIK 1600175

Opus Point Partners Management, LLC

New York, NY · filing since Q4 2014 · last filing Nov 14, 2019
Reported value
$55.3M
$-12.3M vs prior
Positions
55
New / sold out
2 / 10
Added / reduced
18 / 1
Turnover
2.6%
buys $1.6M · sells $5.6M
Top-10 weight
62.6%

Biggest buys vs Q2 2019

ChangeSecurityShares changeChange %Est. trade value
AddedFORTRESS BIOTECH INC+379,521+162.2%+$535.1K
NewUNITED THERAPEUTICS CORP DEL+3,498–+$279.0K
AddedAMARIN CORP PLC+17,000+102.2%+$257.7K
NewALKERMES PLC+11,632–+$227.0K
AddedREGENERON PHARMACEUTICALS+218+9.8%+$60.5K
AddedDIREXION SHS ETF TR+1,423+1.4%+$44.0K
AddedFIBROGEN INC+859+17.6%+$31.7K
AddedLIGAND PHARMACEUTICALS INC+317+15.0%+$31.6K
AddedEXELIXIS INC+1,692+14.8%+$29.9K
AddedALNYLAM PHARMACEUTICALS INC+333+2.5%+$26.8K
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q2 2019

ChangeSecurityShares changeChange %Est. trade value
Sold outIMMUNOMEDICS INC-62,575-100.0%$-868.0K
Sold outSAREPTA THERAPEUTICS INC-5,353-100.0%$-813.0K
Sold outBLUEBIRD BIO INC-5,840-100.0%$-743.0K
Sold outINSMED INC-26,936-100.0%$-690.0K
Sold outPACIRA BIOSCIENCES-11,250-100.0%$-489.0K
Sold outAMICUS THERAPEUTICS INC-36,731-100.0%$-458.0K
Sold outVIKING THERAPEUTICS INC-48,485-100.0%$-402.0K
Sold outMADRIGAL PHARMACEUTICALS INC-3,570-100.0%$-374.0K
Sold outANAPTYSBIO INC-6,116-100.0%$-345.0K
Sold outAGIOS PHARMACEUTICALS INC-4,806-100.0%$-240.0K
1 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2014: $101.1MQ1 2015: $119.3MQ2 2015: $126.3MQ3 2015: $181.1MQ4 2015: $151.4MQ1 2016: $129.4MQ2 2016: $103.5MQ3 2016: $178.3MQ4 2016: $125.5MQ1 2017: $134.7MQ2 2017: $109.2MQ3 2017: $111.5MQ4 2017: $115.6MQ1 2018: $51.0MQ2 2018: $46.1MQ3 2018: $41.9MQ4 2018: $45.4MQ1 2019: $73.8MQ2 2019: $67.6MQ3 2019: $55.3M
Q4 2014Q3 2019

Holdings · Q3 2019

#SecuritySharesValueWeight
1ISHARES TRNASDAQ BIOTECH125,000$12.4M22.48%
2ISHARES TRCALLNASDAQ BIOTECH85,000$8.5M15.28%
3DIREXION SHS ETF TRSP BIOTCH BL NEW99,855$3.1M5.58%
4METTLER TOLEDO INTERNATIONALCOM3,235$2.3M4.12%
5BRISTOL MYERS SQUIBB COCOM33,000$1.7M3.02%
6SEATTLE GENETICS INCCOM18,020$1.5M2.78%
7ILLUMINA INCCOM4,721$1.4M2.59%
8VERTEX PHARMACEUTICALS INCCOM8,279$1.4M2.54%
9IONIS PHARMACEUTICALS INCCOM20,124$1.2M2.18%
10ALNYLAM PHARMACEUTICALS INCCOM13,684$1.1M1.99%
45 more rows. Subscribe for $29/month to see every row, download the data and use the API.